US Patent Issued to SHANGHAI YUANSONG BIOTECHNOLOGY on June 3 for "Oncolytic virus expressing interferon and application therefor" (Chinese Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,931, issued on June 3, was assigned to SHANGHAI YUANSONG BIOTECHNOLOGY Co. LTD. (Shanghai).

"Oncolytic virus expressing interferon and application therefor" was invented by Kangjian Zhang (Shanghai), Xianlong Fang (Shanghai), Jinfa Gu (Shanghai) and Xinyuan Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an oncolytic virus expressing interferon. Specifically provided is an oncolytic adenovirus comprising a fusion protein expressing interferon, said oncolytic virus being capable of effectively suppressing tumors in vitro and in vivo."

The patent was filed on Dec. 24, 2019, under Application No. 17/418,759.

*For further infor...